{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:26:18Z","timestamp":1794637578919,"version":"4.9.1"},"reference-count":49,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,7,19]],"date-time":"2007-07-19T00:00:00Z","timestamp":1184803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Immunophenotypic analysis can identify protein epitopes in non\u2010Hodgkin lymphomas (NHL) that may respond to targeted immunotherapies, such as anti\u2010CD20 and anti\u2010CD52. Recent studies suggest additional targets may provide therapeutic benefits in NHL. This study evaluated protein expression of CD25, CD52, CD74 and CD80 in paediatric NHL to determine possible targets for immune\u2010based therapeutic approaches. Patient samples were derived from paediatric NHL clinical trials sponsored by the Children's Cancer Group (CCG, now the Children's Oncology Group, COG) and included Burkitt lymphoma (BL), diffuse large B\u2010cell lymphoma (DLBCL), disseminated T\u2010 and B\u2010cell lymphoblastic lymphoma (T\u2010LBL and B\u2010LBL) and anaplastic large cell (ALCL). Immunophenotypic studies were performed on formalin\u2010fixed, paraffin\u2010embedded diagnostic tissues. CD25 was expressed in 8% of T\u2010LBL and 75% of ALCL cases, but not in BL, DLBCL, or B\u2010LBL. CD52 was expressed in 99% of cases of paediatric NHL of all subtypes. CD74 was expressed in 100% of B\u2010LBL, BL and DLBCL, but was absent in ALCL and T\u2010LBL. CD80 was expressed in 12% of B\u2010LBL, 6% of BL and 10% of DLBCL cases studied, but was not detected in T\u2010cell NHL. These expression patterns suggest that CD25, CD52 and CD74 may represent potential new therapeutic targets in paediatric NHL.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2007.06689.x","type":"journal-article","created":{"date-parts":[[2007,7,19]],"date-time":"2007-07-19T14:46:34Z","timestamp":1184856394000},"page":"506-512","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Immunophenotypic identification of possible therapeutic targets in paediatric non\u2010Hodgkin lymphomas: a children's oncology group report"],"prefix":"10.1111","volume":"138","author":[{"given":"Rodney R.","family":"Miles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell S.","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Satwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Zwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Lones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sposto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minnie","family":"Abromovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Tripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherrie L.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,7,19]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"161a","DOI":"10.1182\/blood.V108.11.533.533","article-title":"Results of CCG\u20105941: intensified multiagent chemotherapy and non\u2010cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents","volume":"108","author":"Abromowitch M.","year":"2006","journal-title":"Blood"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.6.1024"},{"key":"e_1_2_6_4_1","first-page":"3591","article-title":"CD30(+) anaplastic large\u2010cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Paediatric Oncology","volume":"92","author":"Brugieres L.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008352726155"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402402"},{"key":"e_1_2_6_7_1","first-page":"796","article-title":"Results of a randomized FAB LMB96 international study in children and adolescents (C+A) with advanced (bone marrow [BM] [B\u2010ALL] and\/or CNS) B\u2010NHL (large cell [LCL], Burkitt's [BL] and Burkitt\u2010like [BLL]): Pts with L3 leukemia\/CNS\u2010 have an excellent prognosis","volume":"22","author":"Cairo M.S.","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10262"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04134.x"},{"key":"e_1_2_6_10_1","first-page":"1962","volume-title":"Cancer Medicine","author":"Cairo M.S.","year":"2006"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/85251"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81025-9"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.018"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"2641a","DOI":"10.1182\/blood.V104.11.2641.2641","article-title":"Interim analysis of a phase II study of denileukin diftitox (Ontak) for relapsed\/refractory T\u2010cell non\u2010Hodgkin's lymphoma","volume":"11","author":"Dang N.","year":"2004","journal-title":"Blood"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2006.01.029"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.11.4297"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.6.1431.1431"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401939"},{"key":"e_1_2_6_19_1","first-page":"795","article-title":"Results of the FAB international study in children and adolescents with localised resected B\u2010cell lymphoma (large cell, Burkitt and Burkitt\u2010like) [abstract]","volume":"22","author":"Gerrard M.","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_20_1","first-page":"855","article-title":"Rituximab (R) pharmocokinetics in paediatric patients with newly diagnosed advanced stage mature B\u2010cell lymphoma and leukemia:\u00a0results of a subpilot of COG study ANHLO1P1","volume":"46","author":"Goldman S.D.G.","year":"2006","journal-title":"Pediatric Blood & Cancer"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/146532401753174098"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3200293"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1200\/JCO.1993.11.9.1682","article-title":"Clinical activity of a cytotoxic fusion protein in the treatment of cutaneous T\u2010cell lymphoma","volume":"11","author":"Hesketh P.","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_25_1","volume-title":"Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe E.S.","year":"2001"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.1.205"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.10.3554"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.9.2390"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.4049\/jimmunol.148.11.3478","article-title":"Assembly and transport properties of invariant chain trimers and HLA\u2010DR\u2010invariant chain complexes","volume":"148","author":"Lamb C.A.","year":"1992","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710303371802"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.004"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.1.92"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00868.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.4.1567"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3370"},{"key":"e_1_2_6_36_1","first-page":"796","article-title":"Results of the randomised international trial FAB LMB96 for the \u2018\u2018intermediate risk\u2019\u2019 childhood and adolescent B\u2010cell lymphoma: reduced therapy is efficacious [abstract]","volume":"22","author":"Patte C.","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_37_1","first-page":"314","article-title":"B\u2010cell non\u2010Hodgkin's lymphoma in children and adolescents: surface antigen expression and clinical implications for future targeted bioimmune therapy: a children's cancer group report","volume":"1","author":"Perkins S.L.","year":"2003","journal-title":"Clinical Advances in Hematology & Oncology"},{"key":"e_1_2_6_38_1","first-page":"3294","article-title":"Improved treatment results in childhood B\u2010cell neoplasms with tailored intensification of therapy: a report of the Berlin\u2010Frankfurt\u2010Munster Group Trial NHL\u2010BFM 90","volume":"94","author":"Reiter A.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_39_1","first-page":"416","article-title":"Intensive ALL\u2010type therapy without local radiotherapy provides a 90% event\u2010free survival for children with T\u2010cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter A.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1275"},{"key":"e_1_2_6_41_1","first-page":"1009","article-title":"CD22 and CD74 expression in B\u2010precursor acute lymphoblastic leukemia (pre\u2010B ALL) and significant cytotoxicity of anti\u2010CD22 and anti\u2010CD74 antibodies: Implications for targeted immunotherapy","volume":"46","author":"Roman E.","year":"2005","journal-title":"Proceedings of the American Association of Cancer Research"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.5.895"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605093341906"},{"key":"e_1_2_6_44_1","first-page":"538a","article-title":"CD25 is highly expressed in childhood ALCL and may be an excellent target for denileukin diftitox fusion protein","volume":"19","author":"Satwani P.","year":"2004","journal-title":"Cancer Biotherapy & Radiopharmaceuticals"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.3699"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0890"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M105902200"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.11.6088"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/1.6.493"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2003.n.008"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2007.06689.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2007.06689.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:36:15Z","timestamp":1697423775000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2007.06689.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,19]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1365-2141.2007.06689.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06689.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,19]]},"assertion":[{"value":"2007-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}